AI assistant
Sending…
STANDARD BIOTOOLS INC. — Director's Dealing 2022
Apr 8, 2022
32853_dirs_2022-04-08_37922393-fb66-46ef-8f03-8103d35ef068.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STANDARD BIOTOOLS INC. (LAB)
CIK: 0001162194
Period of Report: 2022-04-06
Reporting Person: Caligan Partners LP (10% Owner)
Reporting Person: JOHNSON DAVID EDWARD (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-04-06 | Common Stock, $0.001 par value per share ("Common Stock") | P | 109573 | $3.60 | Acquired | 8489838 | Indirect |
| 2022-04-07 | Common Stock | P | 200000 | $3.88 | Acquired | 8689838 | Indirect |
| 2022-04-08 | Common Stock | P | 200000 | $3.76 | Acquired | 8889838 | Indirect |
Footnotes
F1: The securities reported herein are held by an affiliated fund and managed account of Caligan Partners LP ("Caligan"). David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan.
More from STANDARD BIOTOOLS INC.
Proxy Solicitation & Information Statement
2026
Apr 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24
Regulatory Filings
2026
Feb 24
Regulatory Filings
2026
Feb 5
Regulatory Filings
2026
Jan 30